Enveric Biosciences, Inc.
ENVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000890821
No open-market purchases or sales by Enveric Biosciences, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $736.8K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Enveric Biosciences, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +7 vs. Q3 2021
- Shares held
- 4.78M
- +2.54M (+113.5%) vs. Q3 2021
- Total value
- $4.45M
- −$195.0K (−4.2%) vs. Q3 2021
- New holders
- 9
- 12 more added
- Sold out
- 2
- 5 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENVB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $736.8K |
| Q1 2026 | 11 | $106.6K |
| Q4 2025 | 11 | $87.7K |
| Q3 2025 | 11 | $232.6K |
| Q2 2025 | 14 | $283.2K |
| Q1 2025 | 15 | $344.7K |
| Q4 2024 | 19 | $386.7K |
| Q3 2024 | 17 | $337.2K |
| Q2 2024 | 17 | $307.3K |
| Q1 2024 | 18 | $488.4K |
| Q4 2023 | 15 | $635.8K |
| Q3 2023 | 15 | $518.3K |
| Q2 2023 | 14 | $631.1K |
| Q1 2023 | 13 | $382.4K |
| Q4 2022 | 12 | $356.8K |
| Q3 2022 | 12 | $623.0K |
| Q2 2022 | 27 | $1.99M |
| Q1 2022 | 31 | $3.61M |
| Q4 2021 | 31 | $4.45M |
| Q3 2021 | 24 | $4.64M |
| Q2 2021 | 18 | $2.72M |
| Q1 2021 | 14 | $3.42M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Enveric Biosciences, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 760,589 | $707.0K | 0.00% | +264,936+53.5% | Added |
| Pura Vida Investments, LLC | 742,046 | $690.0K | 0.07% | +742,046 | New |
| Renaissance Technologies LLC | 554,100 | $515.0K | 0.00% | +61,547+12.5% | Added |
| BlackRock Inc. | 501,378 | $466.0K | 0.00% | +1,300+0.3% | Added |
| Ikarian Capital, LLC | 400,000 | $372.0K | 0.11% | +400,000 | New |
| Mirae Asset Global Investments Co., Ltd. | 392,920 | $365.0K | 0.00% | +392,920 | New |
| AdvisorShares Investments LLC | 300,524 | $279.0K | 0.03% | +264,770+740.5% | Added |
| Geode Capital Management, LLC | 166,537 | $154.0K | 0.00% | +51,275+44.5% | Added |
| Citadel Advisors LLC | 155,137 | $144.0K | 0.00% | +68,488+79.0% | Added |
| Virtu Financial LLC | 140,710 | $131.0K | 0.01% | +86,253+158.4% | Added |
| Price T Rowe Associates Inc | 138,900 | $129.0K | 0.00% | +85,800+161.6% | Added |
| State Street Corp | 88,886 | $83.0K | 0.00% | 00.0% | Unchanged |
| Scotia Capital Inc. | 66,155 | $62.0K | 0.00% | −28,240−29.9% | Reduced |
| Goldman Sachs Group Inc | 58,915 | $55.0K | 0.00% | +58,915 | New |
| Group One Trading, L.P. | 52,283 | $49.0K | 0.00% | +52,283 | New |
| Boothbay Fund Management, LLC | 44,160 | $41.0K | 0.00% | +44,160 | New |
| Two Sigma Investments, LP | 42,050 | $39.0K | 0.00% | −1,750−4.0% | Reduced |
| Northern Trust Corp | 36,504 | $34.0K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 32,852 | $31.0K | 0.00% | +4,091+14.2% | Added |
| Vident Investment Advisory, LLC | 26,268 | $24.0K | 0.00% | +1,116+4.4% | Added |
| Susquehanna International Group, LLP | 20,605 | $19.0K | 0.00% | +20,605 | New |
| Creative Planning | 17,577 | $16.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 13,966 | $13.0K | 0.00% | +13,489+2,827.9% | Added |
| Integrated Wealth Concepts LLC | 10,801 | $10.0K | 0.00% | −33,640−75.7% | Reduced |
| Cutler Group LP | 5,900 | $5.00K | 0.00% | −100−1.7% | Reduced |
| Rinkey Investments | 6,500 | $5.00K | 0.00% | +6,500 | New |
| Advisor Group Holdings, Inc. | 4,000 | $4.00K | 0.00% | −150−3.6% | Reduced |
| Simplex Trading, LLC | 3,158 | $2.00K | 0.00% | +3,158 | New |
| Wells Fargo & Company | 904 | $1.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2 | $0 | 0.00% | +1+100.0% | Added |
| FNY Investment Advisers, LLC | 40 | $0 | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −13,273−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,571−100.0% | Sold out |